Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-21

FDA Approved: NITISINONE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nitisinone from Endo USA, Inc., updating regulatory approval for this drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitisinone (Nitisinone)

Snippet

SUPPL AP for NITISINONE (NITISINONE)